Myeloma Cell Associated Therapeutic Protein Discovery Using Single Cell RNA-Seq Data

多发性骨髓瘤 免疫系统 细胞毒性T细胞 浆细胞骨髓瘤 生物 抗体 等离子体电池 细胞内 癌症研究 细胞 免疫学 细胞生物学 遗传学 体外
作者
Lijun Yao,Reyka Jayasinghe,Tianjiao Wang,Julie O’Neal,Ruiyang Liu,Michael P. Rettig,Chia‐Feng Tsai,Steven M. Foltz,Daniel Kohnen,Smrithi Mani,Fernanda Martins Rodrigues,Michael C. Wendl,Matthew A. Wyczalkowski,Scott Goldsmith,Ying Zhu,Mark A. Fiala,Tao Liu,Ravi Vij,Li Ding,John F. DiPersio
出处
期刊:Blood [Elsevier BV]
卷期号:136 (Supplement 1): 4-5 被引量:2
标识
DOI:10.1182/blood-2020-142205
摘要

Multiple myeloma (MM) is a hematological cancer of the antibody-secreting plasma cells. Despite therapeutic advancements, MM remains incurable due to high incidence of drug-resistant relapse. In recent years, targeted immunotherapies, which take advantage of the immune system's cytotoxic defenses to specifically eliminate tumor cells expressing certain cell surface and intracellular proteins have shown promise in combating this and other B cell hematologic malignancies. A major limitation in the development of these therapies lies in the discovery of optimal candidate targets, which require both high expression in tumor cells as well as stringent tissue specificity. In an effort to identify potential myeloma-specific target antigens, we performed an unbiased search for genes with specific expression in plasma and/or B cells using single-cell RNA-sequencing (scRNAseq) of 53 bone marrow samples taken from 42 patients. By comparing >40K plasma cells to >97K immune cells across our cohort, we were able to identify a total of 181 plasma cell-associated genes, including 65 that encode cell-surface proteins and 116 encoding intracellular proteins. Of particular interest is that the plasma cells from each patient were shown to be transcriptionally distinct with unique sets of genes expressed defining each patient's malignant plasma cells. Using pathway enrichment analysis, we found significant overrepresentation of cellular processes related to B-Cell receptor (BCR) signaling, protein transport, and endoplasmic reticulum (ER) stress, involving genes such as DERL3, HERPUD1, PDIA4, PDIA6, RRBP1, SSR3, SSR4, TXNDC5, and UBE2J1. To note, our strategy successfully captured several of the most promising MM therapeutic targets currently under pre-clinical and clinical trials, including TNFRSF17(BCMA), SLAMF7, and SDC1 (CD138). Among these, TNFRSF17 showed very high plasma cell expression, with concomitant sharp exclusion of other immune cell types. To ascertain tissue specificity of candidate genes outside of the bone marrow, we analyzed gene and protein expression data from the Genotype-Tissue Expression (GTEx) portal and Human Protein Atlas (HPA). We found further support for several candidates (incl. TNFRSF17,SLAMF7, TNFRSF13B (TACI), and TNFRSF13C) as being both exclusively and highly expressed in lymphoid tissues. While several surface candidates were not found to be lymphocyte-restricted at the protein level, they remain relevant considerations as secondary targets for bi-specific immunotherapy approaches currently under development. To further investigate potential combinatorial targeting, we examine sample-level patterns of candidate co-expression and mutually-exclusive expression using correlation analysis. As the majority of our detected plasma cell-specific genes encode intracellular proteins, we investigated the potential utility of these epitopes as therapeutic targets via MHC presentation. Highly expressed candidates include MZB1, SEC11C, HLA-DOB, POU2AF1, and EAF2. We analyzed protein sequences using NetMHC and NETMHCII to predict high-affinity peptides for common class-I and class-II HLA alleles. To correlate MHC allelic preference with candidate expression in our cohort, we performed HLA-typing for 29 samples using Optitype. To support our scRNAseq-driven findings, we cross-referenced gene expression data with 907 bulk RNA-sequencing samples, including 15 from internal studies and 892 from the Multiple Myeloma Research Foundation (MMRF), as well as bulk global proteomics data from 4 MM cell lines (TIB.U266, RPMI8226, OPM2, MM1ST) and 4 patients. We see consistent trends across both cohorts, with high positive correlation (Pearson R ranging between 0.60 and 0.99) for a majority of genes when comparing scRNA and bulk RNA expression in the same samples. Our experimental design and analysis strategies enabled the efficient discovery of myeloma-associated therapeutic target candidates. In conclusion, this study identified a set of promising myeloma CAR-T targets, providing novel treatment options for myeloma patients. Disclosures Goldsmith: Wugen Inc.: Consultancy. DiPersio:Magenta Therapeutics: Membership on an entity's Board of Directors or advisory committees.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
风铃鸟发布了新的文献求助10
刚刚
521完成签到,获得积分20
刚刚
future完成签到 ,获得积分10
5秒前
脾气暴躁的小兔完成签到,获得积分10
6秒前
慕青应助噜噜采纳,获得10
6秒前
乐观期待完成签到,获得积分10
9秒前
9秒前
11秒前
噜噜完成签到,获得积分10
12秒前
JJ发布了新的文献求助10
13秒前
SciGPT应助Charlie采纳,获得10
14秒前
所所应助jenny_shjn采纳,获得10
15秒前
噜噜发布了新的文献求助10
17秒前
18秒前
fyjlfy完成签到 ,获得积分10
19秒前
勿明应助刀锋采纳,获得50
24秒前
25秒前
大气金毛完成签到 ,获得积分10
26秒前
huahua发布了新的文献求助10
31秒前
Limerencia完成签到,获得积分10
31秒前
考拉发布了新的文献求助10
32秒前
Linden_bd完成签到 ,获得积分10
32秒前
唐新惠完成签到 ,获得积分10
32秒前
充电宝应助你想读博吗采纳,获得10
33秒前
lightgo应助科研通管家采纳,获得10
35秒前
华仔应助科研通管家采纳,获得10
36秒前
思源应助科研通管家采纳,获得10
36秒前
充电宝应助科研通管家采纳,获得10
36秒前
lightgo应助科研通管家采纳,获得10
36秒前
36秒前
彭于晏应助科研通管家采纳,获得10
36秒前
勤恳的黑夜完成签到 ,获得积分10
36秒前
38秒前
在水一方应助Li采纳,获得10
40秒前
43秒前
236完成签到,获得积分10
43秒前
44秒前
CornellRong发布了新的文献求助200
48秒前
48秒前
48秒前
高分求助中
The Mother of All Tableaux Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 2400
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
Optimal Transport: A Comprehensive Introduction to Modeling, Analysis, Simulation, Applications 800
Official Methods of Analysis of AOAC INTERNATIONAL 600
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
T/CIET 1202-2025 可吸收再生氧化纤维素止血材料 500
Interpretation of Mass Spectra, Fourth Edition 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3950988
求助须知:如何正确求助?哪些是违规求助? 3496397
关于积分的说明 11081817
捐赠科研通 3226886
什么是DOI,文献DOI怎么找? 1784005
邀请新用户注册赠送积分活动 868114
科研通“疑难数据库(出版商)”最低求助积分说明 800997